Esperion Therapeutics | Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.55B 757M 2025-12
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
Amarin USD 16.89M 18.51M 2025-03
Amgen USD 1.79B 128M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Cipla INR 29.1B 1.16B 2025-12
CSL USD 1.79B 2.15B 2025-06
Cytokinetics USD 112.55M 12.71M 2025-06
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Geron USD 1.04M 147K 2025-09
Grifols EUR 1.32B 22.75M 2025-09
Halozyme Therapeutics USD 73M 8.88M 2025-09
Heron Therapeutics USD 9.46M 1.61M 2024-09
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
Merck USD 3.32B 531M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 207M 88M 2025-09
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 23.32M 7.83M 2025-09
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Sanofi EUR 4.29B 421M 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
United Therapeutics USD 100.9M 74.3M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Esperion Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.